SpyGlass Pharma, Inc.
Quick facts
Phase 3 pipeline
- Bimatoprost Implant System · Ophthalmology
Bimatoprost is a prostaglandin F analog that increases uveoscleral outflow of aqueous humor to reduce intraocular pressure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: